Saniona: Another collaboration with Big Pharma validates Saniona’s unique business model
Research Note
2020-03-27
08:39
Saniona enters into a second collaboration with Boehringer Ingelheim (BI) to develop new and innovative treatments in Schizophrenia.
AH
Anders Hedlund
Disclosures and disclaimers